Covidence alternatives include Rayyan (free), ASReview (free, open-source), SysRev (free), RevMan (free from Cochrane), EPPI-Reviewer (free for UK institutions), DistillerSR (paid enterprise), Nested Knowledge (paid with automation), and Research Gold's free systematic review tools. Covidence remains the most widely used screening and data extraction platform for systematic reviews, but its pricing model, which charges $240 to $450 per year per reviewer on paid plans, creates a significant barrier for unfunded researchers, graduate students, and teams in low-resource settings. This comparison evaluates each alternative on pricing, screening capabilities, collaboration features, data extraction support, and overall fit for different research contexts.
Why Researchers Look Beyond Covidence
The most common reason researchers seek Covidence alternatives is cost. Covidence offers a free tier, but it restricts users to a single active review with limited functionality. Once you need a second project or want access to data extraction templates, quality assessment tools, or PRISMA flow diagram generation, you must upgrade to a paid subscription.
Individual researcher plans cost approximately $240 per year. Institutional licenses range from $3,000 to $12,000 per year depending on the number of seats. For a team of three reviewers working on two concurrent systematic reviews, the annual cost can reach $720 to $1,350 before any institutional discount applies.
Beyond pricing, researchers cite several other reasons for exploring alternatives. Limited customization of data extraction forms frustrates teams conducting reviews with complex or non-standard outcomes. The platform's lack of built-in meta-analysis means you need separate software (such as R with the metafor package or RevMan) to analyze your extracted data. Some researchers also find that Covidence's rigid workflow, while excellent for Cochrane-style reviews, does not adapt well to scoping reviews, rapid reviews, or integrative reviews that follow different methodological frameworks.
The JBI Manual for Evidence Synthesis and the Cochrane Handbook both acknowledge that multiple software platforms can support rigorous systematic review conduct. No single tool holds a monopoly on methodological quality.
Tool-by-Tool Comparison
1. Rayyan (Free with Optional Premium)
Rayyan is the most popular free alternative to Covidence, developed by the Qatar Computing Research Institute (QCRI). It focuses primarily on the title and abstract screening phase and has been cited in thousands of published systematic reviews.
Pricing: Free for unlimited reviews and unlimited collaborators. A premium tier (Rayyan Teams) adds advanced features, but the core screening functionality remains completely free.
Key features: Blind screening mode for independent reviewer decisions, AI-assisted duplicate detection, keyword highlighting, labeling and categorization, and one-click PRISMA flow diagram export. Rayyan supports imports from PubMed, Embase, Web of Science, and most reference managers via RIS or BibTeX files.
Pros: Genuinely free with no project limits. The machine learning predictions help prioritize likely-relevant records during screening. The interface is intuitive and requires minimal training. Collaboration features work well for distributed teams.
Cons: Data extraction capabilities are limited compared to Covidence. The platform focuses heavily on screening and does not support the full systematic review workflow. Occasional slowdowns occur with very large reference libraries (over 10,000 records). No built-in quality assessment or risk of bias tools.
Best for: Graduate students, unfunded researchers, and teams that primarily need a robust screening platform and plan to use separate tools for data extraction and analysis.
For a detailed head-to-head comparison, see our guide on Covidence vs Rayyan.
2. DistillerSR (Paid Enterprise)
DistillerSR by Evidence Partners targets organizations conducting multiple systematic reviews simultaneously. It is the most feature-rich alternative to Covidence and competes directly at the enterprise level.
Pricing: Custom enterprise pricing, typically starting around $4,000 to $8,000 per year for institutional licenses. Individual pricing is not publicly listed. Free trials are available.
Key features: AI-powered reference prioritization that learns from reviewer decisions in real time, fully customizable data extraction forms, built-in quality assessment templates (including Cochrane Risk of Bias 2.0, Newcastle-Ottawa Scale, and AMSTAR 2), automated PRISMA flow diagrams, and comprehensive audit trails for regulatory compliance.
Pros: The most complete systematic review management platform available. AI prioritization can reduce screening time by 30 to 50 percent according to Evidence Partners. Extremely customizable forms adapt to any review type. Enterprise-grade security and compliance features suit hospital systems and government agencies.
Cons: The highest price point of any tool on this list. The learning curve is steeper than Covidence. Smaller teams may find the feature set overwhelming. Setup and configuration require more upfront investment than simpler tools.
Best for: Health technology assessment agencies, Cochrane review groups, hospital evidence synthesis units, and organizations that produce systematic reviews as a core business function.
3. EPPI-Reviewer (Free for UK Institutions)
EPPI-Reviewer is developed by the Evidence for Policy and Practice Information and Co-ordinating Centre at University College London. It has supported evidence synthesis in education, health, and social policy for over two decades.
Pricing: Free for UK higher education and public sector institutions through JISC licensing. International users can access it through institutional agreements or paid subscriptions starting at approximately $500 per year.
Key features: Full workflow coverage from protocol to synthesis, text mining and machine learning for screening prioritization, customizable coding frameworks, built-in meta-analysis capabilities (one of the few tools that includes this), support for qualitative and mixed-methods synthesis, and integration with reference databases.
Pros: The built-in meta-analysis module eliminates the need for separate statistical software for basic analyses. Text mining tools genuinely accelerate screening. Supports review types beyond traditional systematic reviews, including qualitative evidence syntheses and mixed-methods reviews. Long track record in published research.
Cons: The interface feels dated compared to Covidence and Rayyan. The learning curve is significant, particularly for the text mining features. Performance can lag with very large datasets. Documentation could be more comprehensive for new users.
Best for: UK-based researchers (where it is free), teams conducting policy-relevant reviews, and researchers who need built-in statistical analysis without purchasing additional software.
4. ASReview (Free, Open-Source, AI-Powered)
ASReview (Active learning for Systematic Reviews) is an open-source tool developed at Utrecht University that uses active learning to dramatically reduce screening workload.
Pricing: Completely free and open-source. No premium tier, no usage limits, no institutional requirements.
Key features: Active learning algorithms that continuously reorder records based on your screening decisions, placing the most likely relevant studies at the top of your queue. Supports multiple classifier models. Simulation mode lets you benchmark performance against fully screened datasets. Runs locally on your machine or through a hosted version.
Pros: The AI screening assistance is genuinely transformative. Published validation studies show that ASReview can identify 95 percent of relevant records after screening only 10 to 30 percent of the total library. Completely free with no restrictions. Active open-source community with regular updates. Privacy-friendly because data can stay on your local machine.
Cons: Focuses exclusively on screening. No data extraction, no quality assessment, no collaboration features built in. Requires some technical comfort to install locally (though the web version reduces this barrier). The tool assumes you will use other software for subsequent review steps.
Best for: Solo researchers or small teams who want to reduce screening time dramatically and are comfortable using separate tools for data extraction, quality assessment, and analysis.
5. SysRev (Free)
SysRev is a free, web-based platform that supports collaborative screening and data extraction for systematic reviews, with a unique emphasis on transparency and open data.
Pricing: Free for public (open-access) projects. Private projects require a paid subscription.
Key features: Collaborative screening with conflict resolution, customizable data extraction labels, machine learning-assisted screening, project analytics and reviewer agreement metrics, and the ability to share completed reviews as open datasets.
Pros: Genuinely free for open projects. The data extraction system is more flexible than Rayyan's. Reviewer agreement metrics help identify screening inconsistencies early. The open-data philosophy aligns well with transparent research practices.
Cons: The interface is less polished than Covidence or Rayyan. The user community is smaller, which means fewer tutorials and less peer support. Private projects require payment. Limited integration with reference management software compared to competitors.
Best for: Researchers committed to open science who want free screening and data extraction in a single platform, and who do not require their project data to remain private.
6. Nested Knowledge (Paid with Automation)
Nested Knowledge differentiates itself by combining systematic review management with automated evidence mapping and interactive visualizations.
Pricing: Free tier available with limited features. Paid plans start at approximately $500 per year per user, with institutional pricing available.
Key features: Automated search updates that monitor databases for new publications matching your search strategy. Interactive evidence maps that visualize relationships between studies, interventions, and outcomes. Integrated screening, data extraction, and meta-analysis in a single platform. Living systematic review support with continuous updating.
Pros: The evidence mapping and visualization features are unique among systematic review tools. Living review support keeps your review current without starting over. The integrated meta-analysis module means fewer tools in your workflow. Modern interface with a thoughtful user experience.
Cons: Relatively new compared to established platforms, so fewer published validation studies exist. The pricing sits between free tools and enterprise solutions, which may not satisfy either budget-constrained or feature-demanding teams. Smaller user base means fewer community resources.
Best for: Researchers conducting living systematic reviews or those who need interactive evidence maps for stakeholder communication. Also suits teams wanting screening, extraction, and analysis in one platform.
7. RevMan (Free from Cochrane)
RevMan (Review Manager) is Cochrane's official software for preparing and maintaining systematic reviews. RevMan Web is the current cloud-based version.
Pricing: Free for all users. No premium tier. Cochrane provides RevMan at no cost to support evidence synthesis globally.
Key features: Full systematic review workflow from protocol registration through publication. Built-in meta-analysis engine with forest plots, funnel plots, and subgroup analysis. Risk of bias assessment tools aligned with the Cochrane Risk of Bias 2.0 framework. Direct publishing to the Cochrane Library for Cochrane review authors. GRADE evidence certainty assessment.
Pros: Completely free with full functionality. The gold standard for Cochrane reviews with direct integration into Cochrane editorial processes. Built-in statistical analysis eliminates the need for R or Stata for standard meta-analyses. Extensive documentation and training resources through the Cochrane Handbook.
Cons: Designed primarily for Cochrane reviews, so the workflow may feel rigid for non-Cochrane projects. The screening module is less sophisticated than Covidence or Rayyan. Import options are more limited than dedicated screening tools. The interface, while improved in RevMan Web, still prioritizes function over aesthetics.
Best for: Cochrane review authors (mandatory), researchers who want a free all-in-one platform with built-in meta-analysis, and teams that prioritize methodological rigor aligned with Cochrane standards.
8. Research Gold Free Tools (No Account Required)
Research Gold offers a suite of free systematic review tools that handle specific workflow steps without requiring an account, a subscription, or any payment.
Pricing: Completely free. No account required. No usage limits.
Key features: PRISMA flow diagram generator that creates publication-ready flow charts from your screening numbers. Data extraction template builder that generates customizable extraction forms for any review type. Reference deduplication tool that identifies and removes duplicate records across multiple database exports. Inclusion and exclusion criteria builder that structures your eligibility framework using the PICOS format. Additional tools for effect size calculation, forest plot generation, and risk of bias visualization.
Pros: No login or account creation needed. Each tool serves a focused purpose and works independently. Tools complement any primary screening platform (use Rayyan for screening, Research Gold tools for PRISMA diagrams and extraction templates). All outputs are downloadable and journal-ready.
Cons: These are individual tools, not an integrated review management platform. They do not replace the collaborative screening workflow of Covidence or Rayyan. Best used alongside a primary screening tool rather than as a standalone solution.
Best for: Any researcher who needs specific systematic review deliverables, such as PRISMA diagrams, extraction templates, or deduplication, without paying for or configuring a full platform. Pairs well with any free screening tool.